Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01843374 |
|---|---|
| Brief Title: | Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma (Tremelimumab) |
| First Submitted : | April 22, 2013 |
| First Submitted that Met QC Criteria : | April 25, 2013 |
| First Posted : | April 30, 2013 (Estimate) |
| Results First Submitted : | April 10, 2017 |
| Results First Submitted that Met QC Criteria : | August 15, 2017 |
| Results First Posted : | August 17, 2017 |
| Certification/Extension First Submitted : | January 24, 2017 |
| Certification/Extension First Submitted that Met QC Criteria : | January 24, 2017 |
| Certification/Extension First Posted : | January 25, 2017 (Estimate) |
| Last Update Submitted that Met QC Criteria : | January 17, 2024 |
| Last Update Posted : | January 19, 2024 |